TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Scholar Rock Holding ( (SRRK) ) just unveiled an update.
Scholar Rock Holding Corporation announced the filing of a prospectus supplement with the SEC for an at-the-market offering program, allowing the sale of up to $200 million in common stock through Jefferies LLC. This move, effective from November 14, 2025, is part of the company’s strategy to raise capital, potentially impacting its financial flexibility and market positioning.
The most recent analyst rating on (SRRK) stock is a Buy with a $49.00 price target. To see the full list of analyst forecasts on Scholar Rock Holding stock, see the SRRK Stock Forecast page.
Spark’s Take on SRRK Stock
According to Spark, TipRanks’ AI Analyst, SRRK is a Neutral.
Scholar Rock’s overall stock score reflects significant challenges due to financial underperformance, including a lack of revenue and ongoing losses. Despite these issues, positive strides in its SMA program and strategic leadership changes indicate potential for future growth. Mixed technical indicators and a weak valuation further moderate the outlook.
To see Spark’s full report on SRRK stock, click here.
More about Scholar Rock Holding
Scholar Rock Holding Corporation operates in the biotechnology industry, focusing on the development of innovative therapies for serious diseases. The company is known for its work on targeting the latent forms of growth factors, which are involved in various biological processes.
Average Trading Volume: 2,516,271
Technical Sentiment Signal: Buy
Current Market Cap: $2.96B
Learn more about SRRK stock on TipRanks’ Stock Analysis page.